AnHorn Medicines: First Subject Dosed in AH-001 Phase I US Trial
26 Mar 2025 //
PR NEWSWIRE
AnHorn Medicines Presents Research of Novel Protein Degrader for Topical Use
15 May 2023 //
PR NEWSWIRE
26 Mar 2025 //
PR NEWSWIRE
15 May 2023 //
PR NEWSWIRE